insomnia
发表于 2025-3-23 12:07:47
F. Z. Baghli,L. El Bakkali,O. Hamdounay be the first clue to the presence of malignancy. The condition can be clinically silent and detected only by automated multiphasic blood chemistry determinations; conversely, it can be the most debilitating aspect of the disease. The disorders of calcium homeostasis that underlie this condition a
vasospasm
发表于 2025-3-23 17:50:10
http://reply.papertrans.cn/23/2279/227829/227829_12.png
moribund
发表于 2025-3-23 20:40:29
Haonan Wang,Biao Hu,Zhengcai Caoent of intestinal tumors is related to the natural history of that tumor, the stage or extent of disease, and the responsiveness of the tumor to various therapeutic modalities. Tumors within the gastrointestinal system are often occult for long periods and present clinically only after extensive dis
ablate
发表于 2025-3-24 02:03:29
http://reply.papertrans.cn/23/2279/227829/227829_14.png
calorie
发表于 2025-3-24 03:33:07
http://reply.papertrans.cn/23/2279/227829/227829_15.png
火花
发表于 2025-3-24 09:41:49
http://reply.papertrans.cn/23/2279/227829/227829_16.png
轻率的你
发表于 2025-3-24 13:24:04
http://reply.papertrans.cn/23/2279/227829/227829_17.png
ear-canal
发表于 2025-3-24 16:09:24
Han Bao,Junyou Yang,Donghui Zhao,Shuoyu Wange of pleural, peritoneal, or pericardial effusions. As many as 50 percent of patients with breast and lung cancers develop pleural effusions, and this complication is common for patients with lymphoma and carcinoma of the ovary as well. Peritoneal effusion, or ascites, occurs most frequently in pati
Mucosa
发表于 2025-3-24 22:18:24
Yuqi Zhou,Hongwei Gao,Jian Sun,Yueqiu Jiang malnutrition (PCM) has recently become evident. Tolerance of and response to specific therapy can be dramatically influenced by nutritional status. Recent developments in clinical nutrition have made nutritional support to reverse PCM possible for most cancer patients. Advances include new techniqu
讲个故事逗他
发表于 2025-3-25 00:48:29
Jianhua Qian,Honghai Liu,Dalin Zhoun is relatively uncommon, and resistance to analgesic therapy is rare. Osier reviewed an extensive group of patients with terminal cancer and found that less than 10 percent required analgesia in the preterminal phase of the disease.